Search PubMed⌕ Search

Biomedical subjects

S L Rasmussen

Publications and source records attributed to S L Rasmussen.

At least 19 recordsLinked to original sources
PubMed2006

Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review.

BACKGROUND/AIMS: Adult xanthogranulomatous disease involving the ocular tissues is rare and poorly understood. Adult onset xanthogranuloma (AOX), adult onset asthma and periocular xanthogranuloma (AAPOX), necrobiotic xanthogranuloma (NBX), and Erdheim-Chester disease (ECD) are the four syndromes within this disorder, which is diagnosed by characteristic histopathology. Experience with eight cases prompted a multi-institutional effort to study the histopathology, immunohistochemistry, clinical findings, and systemic associations in this disorder. METHODS: 22 cases, including histopathological slides, were compiled. Published reports were identified by an English language Medline search (1966-2005) and review of reference citations. Each case in this series and the literature was classified as one of four syndromes and then analysed for age onset, sex, skin xanthoma, orbital location, immune dysfunction, internal organ and bone lesions, treatment, and outcome. The histopathology in each of these cases was reviewed by two pathologists. Immunhistochemical stains (CD3, CD4, CD8, L26) were performed in 14 cases where unstained slides were available. RESULTS: 137 cases were compiled. There was no sex or age difference between syndromes. AOX, AAPOX, NBX affect the anterior orbit, ECD tends to be diffuse and intraconal. Skin lesions are found in all the syndromes. Immune dysfunction was noted in all cases of AAPOX and NBX; 11% of NBX and all ECD patients had internal organ disease. Treatment included surgery, corticosteroids, other chemotherapeutic agents, radiotherapy, and combinations of these. No AOX or AAPOX deaths occurred; 66% of ECD patients died. All 22 cases had xanthoma cells; most had Touton giant cells. Lymphocytes were present in all cases and occurred as aggregates (mostly in AAPOX) or diffuse populations mixed with fibroblasts (mostly in ECD). Immunohistochemistry revealed the majority of these to be CD8+. Necrosis was most marked in NBX. CONCLUSION: Adult xanthogranuloma of the orbit is rare, making prospective evaluation or meta-analysis impossible. The best treatment is unknown but seems to be with multiagent chemotherapy guided by histopathological, immunohistochemical, and systemic findings.

Adolescent↗
PubMed2004

Localised invasive sino-orbital aspergillosis: characteristic features.

BACKGROUND/AIM: To describe the characteristic constellation of historical, clinical, radiographic, and histopathological findings of localised invasive sino-orbital aspergillosis based on the authors' recent experience of four consecutive cases presenting over a 6 month period. Treatment and outcome are reviewed. METHODS: A case series of four patients with review of the English language literature. RESULTS: There have been 17 reported cases of invasive sino-orbital aspergillosis in healthy individuals over the past 33 years. The authors report four patients who presented during a 6 month period with persistent and significant pain followed by progressive ophthalmic signs-clinical histories reflecting the literature. Similar imaging findings were also noted: focal hypodense areas within apical infiltrates on contrasted computed tomography correspond to abscesses seen at surgery, and sinus obliteration or involvement of the adjacent sinus lining was noted on magnetic resonance imaging. Bone erosion (often focal) was also seen. There is frequently a delay in making the correct diagnosis, and often disease progression occurs despite treatment. CONCLUSIONS: The authors encountered four cases of invasive sino-orbital aspergillosis, three of which occurred in otherwise healthy individuals. The clinician must be aware of the characteristic presentation so that earlier diagnosis, management, and improved outcomes can be achieved.

Aged↗
PubMed2001

Cardiovascular risk factors in men: The role of gonadal steroids and sex hormone-binding globulin.

Males have higher risk of cardiovascular disease (CVD) than premenopausal females. Gonadal steroids are probably involved in the gender difference in CVD, but previous results have been conflicting. We investigated the associations between CVD risk factors and sex hormones in a cross-sectional designed study of 508 healthy males, aged 41 to 72 years. We determined total testosterone (T), sex hormone-binding globulin (SHBG), free androgen index (FAI), and estradiol (E2) and studied their relationship to body fat mass (BF), blood pressure (BP), aortic compliance, left ventricular mass (LVM), and plasma lipids (total cholesterol, high-density lipoprotein [HDL], low-density lipoprotein [LDL], very--low-density lipoprotein [VLDL], and triglycerides). In quartile analyses after adjustment for confounders (age, body mass index [BMI], alcohol consumption, and smoking), SHBG and E2 were positively associated with HDL, while FAI was negatively associated with HDL. T and SHBG were negatively associated with VLDL and triglycerides, while FAI was positively associated with VLDL and triglycerides. T and SHBG were negatively associated with BMI and BF, while FAI and E2 were positively associated with BMI and BF. E2 was negatively associated with LVM. No hormone varied with total cholesterol, LDL, BP, and aortic compliance in the adjusted analyses. In multiple regression analyses, SHBG was the main predictive variable of HDL, VLDL, and triglycerides explaining 12%, 17%, and 17% of the variation, respectively. No other hormones were selected as predictive variables for VLDL and triglycerides, but E2, T, and FAI were selected in the HDL regression, explaining 3%, 2%, and less than 1%, respectively. Our regression analyses illustrate the diverging results when investigating associations between gonadal steroids and lipids with and without SHBG adjustment. Atherogenic lipid profile in males is associated with low SHBG, low T levels, and a high FAI. Males with high E2 levels may have a less atherogenic lipid profile and lower LVM. SHBG is a key hormone in the association between sex hormones and plasma lipids. We suggest that conflicting results of cross-sectional and intervention studies of sex hormones and lipids, in part, may be explained by interindividual differences or changes in SHBG. Thus, further studies on the potential role of SHBG in the development of ischemic heart disease (IHD) should be performed.

Adult↗
PubMed1999

Cardiac safety of citalopram: prospective trials and retrospective analyses.

The selective serotonin reuptake inhibitors (SSRIs) are believed to have a more benign cardiovascular safety profile than do the tricyclic antidepressants. The effects of the SSRI citalopram on cardiac conduction and repolarization have been extensively evaluated, both in prospective studies in volunteers and patients and in retrospective evaluations of all electrocardiographic (ECG) data from all clinical trials conducted from 1978 through 1996 (a total of 40 studies). A randomized, double-blind, placebo-controlled study was conducted in healthy volunteers (N = 23) to assess intraindividual variability of the QTc interval, as well as possible changes during treatment with placebo or citalopram, and its correlation to plasma drug levels. To document any dose-related changes, ECGs were performed at baseline and at the end of study in three randomized, double-blind, placebo- or active-controlled, fixed-dose trials in adult and elderly patients (N = 1,460) with major depression and/or dementia. Finally, more than 6,000 ECGs (N = 1,789 citalopram-treated patients) collected from all clinical trials conducted from 1978 through 1996 were reassessed in a standardized manner to identify any effects of citalopram on ECG parameters. Results of both prospective and retrospective analyses showed that the only effect of citalopram on ECG findings is a small reduction in heart rate (< or = 8 beats per minute). There were no significant effects on PQ, QRS, or QTc intervals, indicating that citalopram has no effect on cardiac conduction and repolarization during short- or long-term treatment.

Adolescent↗
PubMed1998

Normal values for ambulatory blood pressure and differences between casual blood pressure and ambulatory blood pressure: results from a Danish population survey.

OBJECTIVE: To determine normal values for 24 h ambulatory blood pressure in a Danish population and to study the relationship to casual blood pressure. STUDY POPULATION: A random sample of 2656 Danish men and women participated in a population survey. The participants were selected in age groups and were aged 41-42, 51-52, 61-62 or 71-72 years during the survey. METHODS; Casual blood pressure (standard mercury sphygmomanometer) and 24 h ambulatory blood pressure (Takeda TM-2421) were measured successfully in 2082 subjects. All subjects under antihypertensive treatment (247) were excluded, restricting the study population to 1835 participants. RESULTS: Casual and 24 h ambulatory blood pressure were correlated (P < 0.0001) in all age and sex groups. Casual systolic/diastolic blood pressures were 129.6+/-17.8/82.6+/-10.3 for men and 125.1+/-18.2/79.7+/-9.9 mmHg for women. Twenty-four-hour average blood pressures were 130.8+/-14.2/75.3+/-8.6 for men and 122.4+/-14.9/69.6+/-8.3 mmHg for women. A multivariate linear logistic regression model confirmed that a high casual blood pressure (odds ratios 11/7 for systolic/diastolic blood pressure; P=0.001) was the major determinant of a lower ambulatory than casual blood pressure; age and sex were less important. CONCLUSION: The relationship between casual blood pressure on the one hand and the difference in casual and 24 h ambulatory blood pressure on the other hand suggests that ambulatory blood pressure represents a regression towards the mean compared to casual blood pressure. Any definition of an upper normal level of 24 h ambulatory blood pressure that is derived from a correlation between casual and ambulatory measurements will be inaccurate, and must await long-term studies of the relationship between ambulatory blood pressure and subsequent cardiovascular events.

Adult↗
PubMed1994

Identification and origin of plant pathogenic microorganisms in recirculating nutrient solutions.

Avoidance of root-infecting microorganisms was originally considered one of the advantages of cultivation of crops in a soilless, recirculating nutrient solution. However, to date, four viral, three bacterial and 21 fungal pathogens have been identified as causal agents of root disease in hydroponically-grown crops. Root-infecting fungi, particularly those which produce a motile stage known as a zoospore, have been the primary pathogens associated with extensive crop losses. Documented sources of these root pathogens in hydroponic systems include peat, surface water such as rivers and streams, and insects. The severity of disease caused by these introduced root pathogens is primarily governed by the genetic susceptibility of each crop and the temperature of the recirculating nutrient solution.

Bacteria↗
PubMed1984

Nodular pulmonary amyloidosis.

An elderly man had a 10-year history of multiple pulmonary nodules that he had refused to have investigated. He died of a ruptured abdominal aortic aneurysm. At autopsy the nodules were shown to consist of amyloid. There was no evidence of systemic amyloidosis.

Aged↗
PubMed1984

"Low T3-syndrome" in acute myocardial infarction--relationship to beta-adrenergic blockade and clinical course.

Serum levels of T4, T3 rT3 and resin T3 uptake were followed for 5 days in 40 patients with acute myocardial infarction (AMI) allocated to early treatment either with alprenolol or placebo. There was a significant fall in T3 (P less than 0.05) and an increase in rT3 (P less than 0.05) without any significant difference between the alprenolol - (n = 19) and placebo - (n = 21) treated groups. The risk of missing a further 20% change in se-T3 and se-rT3 after alprenolol compared to placebo treatment (beta) was less than 0.10 and less than 0.50, respectively. In patients with a severe clinical course, the fall in T3 and increase in rT3 was significantly greater than in patients without complications. No change in T4 was observed either with respect to the clinical course nor following alprenolol. The data suggest that alprenolol can be given in the acute phase of myocardial infarction without causing any additional disturbance in the serum levels of T3 and T4.

Adrenergic beta-Antagonists↗
PubMed1984

201-Thallium imaging as an indicator of graft patency after coronary artery bypass surgery.

In a prospective study, forty-one patients underwent myocardial imaging using 201-thallium (201 Tl) scintigraphy before and 6 months after coronary artery bypass grafting (CABG). The results were compared with the findings at coronary arteriography performed at the same time. 201 Tl was injected at peak exercise level performing an exercise scintigram. A thallium image equivalent to a redistribution scan was obtained at rest approximately 4 h after the injection of 201 Tl. The overall angiographic patency rate was 0.77. Postoperative myocardial perfusion was improved in 26 patients (88%) having 72 of 83 grafts patent (patency rate 0.87). New perfusion defects or unchanged ischaemic patterns were found in 5 patients, who had 2 of 13 grafts patent (graft patency 0.15). Estimation of the graft-status by 201Tl-scintigraphy showed a sensitivity, specificity, and predictive value of a positive and negative result of 0.71, 0.94, 0.79 and 0.91, respectively, using angiographic findings as a reference. It is concluded, that comparison between preoperative and postoperative 201Tl imaging of the myocardium at exercise and rest provides useful information on graft patency after CABG. The procedure is superior at exercise and rest provides useful information on graft patency after CABG. The procedure is superior to graft patency estimation based on resting--or postoperative scintigrams only.

Angina Pectoris↗
PubMed1984

Long-term alprenolol treatment affects serum T4, T3 and rT3 in euthyroid patients with ischaemic heart disease.

After treatment with alprenolol for 1 year, serum 3,3',5'-triiodothyronine (rT3) was significantly increased (P less than 0.01) in a group (n = 20) of euthyroid subjects compared to a control group (n = 20) given placebo. All subjects had definite or suspected myocardial infarction one year previously. Serum thyroxine (T4), free T3 index (FT4I), serum 3,5,3'-triiodothyronine, (T3) and free T3 index (FT3I) were not significantly different in the two groups. Alprenolol and placebo were gradually withdrawn over 14 days. On the first day after withdrawal a significant decrease in serum rT3 in the alprenolol treated group was the only change observed. Fourteen days after withdrawal a significant fall in serum T4, FT4I, rT3 and a rise in serum T3 and FT3I was found in the alprenolol treated group. Six months after withdrawal the only further change observed in the alprenolol treated group was an increase in T3 and FT3I. No changes occurred in the placebo treated group in any of the hormones studied. The results are consistent with a direct effect of long-term alprenolol treatment on the peripheral levels of serum T4, T3 and rT3 in euthyroid subjects. The changes in the thyroid hormones after withdrawal further indicate withdrawal of a permanent inhibition of 5'deiodinase during long-term treatment with alprenolol in euthyroid subjects.

Adult↗